229 related articles for article (PubMed ID: 19414521)
1. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.
Brandner B; Rek A; Diedrichs-Möhring M; Wildner G; Kungl AJ
Protein Eng Des Sel; 2009 Jun; 22(6):367-73. PubMed ID: 19414521
[TBL] [Abstract][Full Text] [Related]
2. A biophysical insight into the RANTES-glycosaminoglycan interaction.
Rek A; Brandner B; Geretti E; Kungl AJ
Biochim Biophys Acta; 2009 Apr; 1794(4):577-82. PubMed ID: 19455751
[TBL] [Abstract][Full Text] [Related]
3. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.
Suffee N; Hlawaty H; Meddahi-Pelle A; Maillard L; Louedec L; Haddad O; Martin L; Laguillier C; Richard B; Oudar O; Letourneur D; Charnaux N; Sutton A
Angiogenesis; 2012 Dec; 15(4):727-44. PubMed ID: 22752444
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
[TBL] [Abstract][Full Text] [Related]
5. Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.
Potzinger H; Geretti E; Brandner B; Wabitsch V; Piccinini AM; Rek A; Kungl AJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):435-7. PubMed ID: 16709180
[TBL] [Abstract][Full Text] [Related]
6. The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance.
Diedrichs-Möhring M; Nelson PJ; Proudfoot AE; Thurau SR; Wildner G
J Neuroimmunol; 2005 Jul; 164(1-2):22-30. PubMed ID: 15921764
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of the RANTES-glycosaminoglycans interactions.
Martin L; Blanpain C; Garnier P; Wittamer V; Parmentier M; Vita C
Biochemistry; 2001 May; 40(21):6303-18. PubMed ID: 11371192
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
9. Defining the anti-inflammatory activity of a potent myxomaviral chemokine modulating protein, M-T7, through site directed mutagenesis.
Bartee MY; Chen H; Dai E; Liu LY; Davids JA; Lucas A
Cytokine; 2014 Jan; 65(1):79-87. PubMed ID: 24211016
[TBL] [Abstract][Full Text] [Related]
10. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
Glycobiology; 2003 Sep; 13(9):623-34. PubMed ID: 12773479
[TBL] [Abstract][Full Text] [Related]
11. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system.
Johnson Z; Kosco-Vilbois MH; Herren S; Cirillo R; Muzio V; Zaratin P; Carbonatto M; Mack M; Smailbegovic A; Rose M; Lever R; Page C; Wells TN; Proudfoot AE
J Immunol; 2004 Nov; 173(9):5776-85. PubMed ID: 15494530
[TBL] [Abstract][Full Text] [Related]
12. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli.
Cho HJ; Lee Y; Chang RS; Hahm MS; Kim MK; Kim YB; Oh YK
Protein Expr Purif; 2008 Jul; 60(1):37-45. PubMed ID: 18455434
[TBL] [Abstract][Full Text] [Related]
13. Recognition of RANTES by extracellular parts of the CCR5 receptor.
Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
[TBL] [Abstract][Full Text] [Related]
14. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ
Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511
[TBL] [Abstract][Full Text] [Related]
15. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization.
Vivès RR; Sadir R; Imberty A; Rencurosi A; Lortat-Jacob H
Biochemistry; 2002 Dec; 41(50):14779-89. PubMed ID: 12475226
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the CC chemokine RANTES from Pekin duck (Anas platyrhynchos).
Arathy DS; Nair S; Soman SS; Issac A; Sreekumar E
Dev Comp Immunol; 2011 Jan; 35(1):142-50. PubMed ID: 20850473
[TBL] [Abstract][Full Text] [Related]
17. Computational design-based molecular engineering of the glycosyl hydrolase family 11 B. subtilis XynA endoxylanase improves its acid stability.
Beliën T; Joye IJ; Delcour JA; Courtin CM
Protein Eng Des Sel; 2009 Oct; 22(10):587-96. PubMed ID: 19531602
[TBL] [Abstract][Full Text] [Related]
18. [Expression in E. coli and chemotactic activity analyzing of recombinant CC-chemokine RANTES].
Sun RH; Wang Y; Zhong YC; Ma DL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):123-6. PubMed ID: 12905886
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration.
Ali S; Fritchley SJ; Chaffey BT; Kirby JA
Glycobiology; 2002 Sep; 12(9):535-43. PubMed ID: 12213786
[TBL] [Abstract][Full Text] [Related]
20. The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic function.
Segerer S; Johnson Z; Rek A; Baltus T; von Hundelshausen P; Kungl AJ; Proudfoot AE; Weber C; Nelson PJ
Mol Immunol; 2009 Aug; 46(13):2533-8. PubMed ID: 19524301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
